Your account is not claimed yet. You can sign up with ORCID to claim your account.

Oliver Hofmann

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 3

Top Topics

Angiotensin Converting Enzyme

Hematopoietic Stem Cell

Dna Damage Response

Top Venues

Science translational medicine

International journal of cancer

University of Melbourne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Melbourne

Australia

Associate Professor :: Center for Cancer Research

Publications

Sigve Nakken, Vladislav Saveliev, Oliver Hofmann, Pål Møller, Ola Myklebost, Eivind Hovig
Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer. International journal of cancer 149 (11) (2021)
Leah K Cuddy, Dmitry Prokopenko, Eric P Cunningham, Ross Brimberry, Peter Song, Rory Kirchner, Brad A Chapman, Oliver Hofmann, Winston A Hide, Daniele Procissi, Taleen Hanania, Steven C Leiser, Rudolph E Tanzi, Robert J Vassar
Aβ-accelerated neurodegeneration caused by Alzheimer's-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice. Science translational medicine 12 (563) (2021)
Leo D Wang, Scott B Ficarro, John N Hutchinson, Roland Csepanyi-Komi, Phi T Nguyen, Eva Wisniewski, Jessica Sullivan, Oliver Hofmann, Erzsébet Ligeti, Jarrod A Marto, Amy J Wagers
Phosphoproteomic profiling of mouse primary HSPCs reveals new regulators of HSPC mobilization. Blood 128 (11) (2016)